Protective Effects of Low Dose Rosuvastatin on Isoproterenol ‐induced Chronic Heart Failure in Rats by Regulation of DDAH‐ADMA‐NO Pathway

ConclusionsLow dose rosuvastatin exerted cardioprotective effects on isoproterenol‐induced heart failure in rats by modulating DDAH‐ADMA‐NO pathway, and it may present the new therapeutic value in ameliorating chronic heart failure.This article is protected by copyright. All rights reserved.
Source: Cardiovascular Therapeutics - Category: Cardiology Authors: Tags: Original Research Article Source Type: research